Abstract: An enhanced labelling complex for localizing markers on a prepared tissue section is disclosed. The complex includes both avidin components and biotinylated macromolecular components at a ratio preselected to provide a complex which is sufficiently large to include a large number of labels, and sufficiently small to penetrate the tissue section. The markers are localized by first introducing a biotinylated link into the tissue section and thereafter exposing the section to the labelling complex.
Abstract: Compounds are described of the general formula: ##STR1## wherein: R.sub.1 is acyl of the formula --C(.dbd.O)--R.sub.5 ; R.sub.2, R.sub.3, and R.sub.4 are each selected from the group consisting of hydrogen and acyl of the formula:--C(.dbd.O)--R.sub.5wherein R.sub.5 is selected from the group consisting of alkyls, substituted alkyls, alkenyls, substituted alkenyls, cycloalkyls, substituted cycloalkyls, arylalkylenes, substituted arylalkylenes, alkylenecycloalkyls, alkylene substituted cycloalkyls, alkynyls, substituted alkynyls, aryls and substituted aryls, wherein R.sub.2, R.sub.3 and R.sub.4 are selected such that at least one of R.sub.2, R.sub.3 and R.sub.4 is an acyl. When R.sub.2, R.sub.3 and R.sub.4 include one or more acyls that are not identical to the acyl of R.sub.1, these compounds of formula I are novel compounds. The invention also includes processes to produce the compounds of formula I. Compounds of formula I complex and/or chelate tissue tri-valent ions, especially iron (Fe.sup.
Abstract: There is disclosed a process for the synthesis of para-nitrodiphenylamines via the Formanilide Process wherein the improvement is characterized in that a specific catalyst is utilized. More specifically, a zinc (II) compound (zinc in the plus two oxidation or valence state), is used as a catalyst in the preparation of para-nitrodiphenylamines via the formanilide process.
Abstract: The invention provides a nickel/alumina/silicate catalyst, with an atomic ratio of nickel/aluminium between 20 and 2, a nickel/silicate ratio between 20 and 1, an active nickel surface area between 70 and 150 m.sup.2 /g nickel and an average pore size, depending on the above atomic ratio, between 4 and 20 nanometers. Preferably the nickel/aluminium atomic ratio is between 10 and 4 and the nickel/silicate ratio between 12 and 3. Preferably the catalyst has a specific porous structure.The invention also provides a method for preparing the catalyst by a two step process involving precipitating nickel ions and adding during a second, so-called ageing step a soluble aluminium compound and optionally the silicate. The silicate is preferably added during a second ageing step.The catalyst is useful for hydrogenating unsaturated organic compounds in particular oils.
Type:
Grant
Filed:
September 17, 1986
Date of Patent:
July 28, 1987
Assignee:
Internationale Octrooi Maatschappij "Octropa" BV
Inventors:
Johannes C. Oudejans, Peter Nootenboom, Keshab L. Ganguli, Cornelis M. Lok
Abstract: A process for producing dimethylamine is provided, comprising reacting methanol and/or dimethylether and ammonia, in amounts sufficient to provide a carbon/nitrogen (C/N) ratio from about 0.2 to about 1.5, and at a temperature from about 250.degree. C. to about 450.degree. C., in the presence of a catalytic amount of a modified acidic zeolite selected from the group consisting of chabazite, erionite, ZK-5, and rho, the zeolite having been modified by treatment with one or more compounds containing at least one element selected from the group consisting of silicon, aluminum, phosphorus, and boron, to deposit thereon at least 0.05 weight percent of the element.
Type:
Grant
Filed:
April 30, 1985
Date of Patent:
July 28, 1987
Assignee:
E. I. Du Pont de Nemours & Company
Inventors:
Horacio E. Bergna, David R. Corbin, George Sonnichsen
Abstract: This invention relates to novel microbial strains which produce phenylalanine ammonia-lyase in the absence of an inducer. Also disclosed is a method for making phenylalanine.
Abstract: A process for producing interferon comprises culturing interferon-producing mammalian cells in a cell culture medium containing at least one compound selected from the group consisting of ascorbic acid, an ascorbic acid derivative and a vanadium compound. According to the process of the present invention, interferon can be produced in large amounts.
Type:
Grant
Filed:
August 30, 1984
Date of Patent:
July 14, 1987
Assignee:
Mochida Pharmaceutical Co., Ltd.
Inventors:
Masahiro Nobuhara, Toshinori Kanamori, Kiyoshi Yamaguchi, Ei Mochida
Abstract: Process for the production of a water-insoluble nitrogeneous organic base, from an aqueous solution of alkali metal bicarbonate and the base hydrochloride, according to which the solution (11) is treated with a complement of the base hydrochloride (12), and the resultant liquid (18) is treated with a basic agent (30) capable of decomposing the hydrochloride. The invention is applied to the regeneration of the amine in the process for the manufacture of sodium bicarbonate by the amines method.
Abstract: A monoclonal antibody against GnRH and particularly designated USASK/DSIL-GnRH is produced by a hybrid formed by fusion of cells from a myeloma line and antibody producing cells of the immune system from an animal previously immunized with a source of GnRH; the monoclonal antibody has the following characteristics:(i) it produces a short term reduced means level of luteinizing hormone (LH) in immunized mammals;(ii) it produces a short term reduced pulsatile secretion of LH in immunized mammals;(iii) it terminates pregnancy in a female mammal with an accompanying decline in progesterone levels;(iv) it produces a long term reduced testosterone level in a male mammal, and(v) it induces infertility in a male mammal; thus passive immunization of the female or male with the monoclonal antibodies may be employed to reduce fertility and terminate pregnancy.
Type:
Grant
Filed:
February 7, 1984
Date of Patent:
June 30, 1987
Assignee:
University of Saskatchewan
Inventors:
David W. Silversides, Reuben J. Mapletoft, Bruce D. Murphy, Vikram Misra
Abstract: Substantially anhydrous hydrocarbyl-substituted chloramine is efficiently prepared by reacting a primary or secondary amine with a chlorinating agent selected from hypochlorous acid or chlorine monoxide in a non-aqueous reaction medium, without co-production of an amine hydrochloride salt.
Abstract: Polyunsaturated fatty acid moieties in fish oil are concentrated by transesterifying fish oil glycerides with a lower alkanol to form a mixture of lower alkyl fatty acid esters, and extracting the esters with carbon dioxide under supercritical conditions.
Type:
Grant
Filed:
June 24, 1986
Date of Patent:
June 23, 1987
Assignee:
The United States of America as represented by the Secretary of Commerce
Abstract: A process for eliminating N-nitrosamines, particularly N,N-dialkyl-N-nitrosamines and N-alkyl-N-aryl-N-nitrosamines from N-nitrosamine containing compositions through the addition of organic carboxylic acid halides. The process eliminates N-nitroso compounds without rearrangement to C-nitroso compounds.
Abstract: A process is disclosed for recovering fats and oils from oil fruits and oil seeds, wherein the oil fruits and oil seeds are cleaned, immediately thereafter pressed cold in a screw press without prior mechanical conditioning, and then extracted. In this process, the extraction is effected immediately after pressing by treating the oil fruits and oil seeds with countercurrently flowing carbon dioxide, ethane, ethene and/or propane at a temperature of from 40.degree. to 110.degree. C. and at a pressure of from 250 to 750 bar, for a time period of from 0.5 to 2.5 hours, with the solvent ratio lying between 5 and 30 kg solvent per 1 kg pressed cake. The separation of the extracted fats and oils from the separated solvent phase is effected by pressure reduction and/or temperature change. The invention also includes an apparatus for implementing the process.
Type:
Grant
Filed:
June 22, 1984
Date of Patent:
June 23, 1987
Assignee:
Fried. Krupp Gesellschaft mit beschrankter Haftung
Abstract: A process for preparing human T cell hybridomas which are subculturable and produce lymphokines comprising the steps of: (1) treating a human acute leukemia cell with a protein and/or RNA synthesis inhibitor; (2) independently activating a human T cell with a mitogen or antigen; (3) fusing the thus-treated human acute leukemia cell with the thus-activated human T cell in the presence of a fusion accelerator; and (4) isolating the thus-formed hybridoma. An in vivo process for producing lymphokines using the hybridomas is also described.
Abstract: A murine monoclonal antibody combining site produced by a hybridoma formed by fusion of cells from a myeloma cell line and lymphocytes that produce antibodies that react (1) with isolated human C3b receptor and (2) with C3b receptor-bearing cells from a mammal immunized with human C3b receptor is disclosed.
Abstract: The present invention provides a process for obtaining a fatty acid product from a glyceride oil soapstock. The process includes the following steps:(a) An acidulated soapstock is formed by reacting the glyceride oil soapstock with an aqueous mineral acid solution.(b) The acidulated soapstock is separated into an aqueous solution and a fatty material/emulsified sludge material mixture.(c) The fatty/sludge mixture is dried to a moisture content of less than about 5%, such that the emulsion in the emulsified sludge material is substantially broken.(d) The dried fatty/sludge mixture is separated into the fatty acid product and a solids residue.
Abstract: This invention is directed to the preparation of .alpha.-sulfofatty acid esters. More particularly, this invention is directed to a process for the simplified preparation of light-colored, wash-active esters of .alpha.-sulfofatty acids with monovalent C.sub.1 to C.sub.8 alcohols or their salts from fats and oils of vegetable and/or animal origin comprising re-esterification with the monovalent alcohols or saponification and esterification with the monovalent alcohols, separation of the fatty acid ester formed, hydrogenation of the fatty acid ester, sulfonation, and bleaching, wherein a fatty acid ester fraction from which accompanying fatty acid glycerides have been removed to the extent of about 1 percent by weight or less, based upon the weight of the material to be sulfonated, is introduced into the sulfonation stage.
Type:
Grant
Filed:
July 31, 1981
Date of Patent:
June 9, 1987
Assignee:
Henkel Kommanditgesellschaft auf Aktien
Inventors:
Karl Schmid, Werner Stein, Horst Baumann
Abstract: Compounds are described of the general formula: ##STR1## wherein: R.sub.1 is acyl of the formula --C(.dbd.O)--R.sub.5 ; R.sub.2, R.sub.3, R.sub.4, R.sub.6, R.sub.7 and R.sub.8 are each selected from the group consisting of hydrogen and acyl of the formula:--C(.dbd.O)--R.sub.5wherein R.sub.5 is selected from the group consisting of alkyls, substituted alkyls, alkenyls, substituted alkenyls, cycloalkyls, substituted cycloalkyls, arylalkylenes, substituted arylalkylenes, alkylenecycloalkyls, alkylene substituted cycloalkyls, alkynyls, substituted alkynyls, aryls and substituted aryls, wherein R.sub.2, R.sub.3 and R.sub.4 are selected such that at least one of R.sub.2, R.sub.3 and R.sub.4 is an acyl. When R.sub.2, R.sub.3 and R.sub.4 include one or more acyls that are not identical to the acyl of R.sub.1, these compounds of formula I are novel compounds. The invention also includes processes to produce the compounds of formula I.
Abstract: Novel alkyl-dinitrodiphenylamine compounds are useful in controlling insects and arachnids. These compounds are useful especially in the control of citrus rust mite.
Abstract: (Hydrocarbylthio)aromatic polyamines are prepared by reacting an aromatic polyamine, such as a diaminobenzene, with a hydrocarbyl disulfide, such as an alkyl disulfide, in the presence of an iodide or bromide of a metal other than an alkali metal as a catalyst.